US2022118173A1PendingUtilityA1

Mixing/administration system for vaccines and medicaments

Assignee: HYPROTEK INCPriority: Jul 10, 2018Filed: Nov 1, 2021Published: Apr 21, 2022
Est. expiryJul 10, 2038(~12 yrs left)· nominal 20-yr term from priority
A61J 1/2096A61M 2205/3561A61M 2205/52A61J 1/2065A61M 5/31596A61M 2205/6072A61M 2205/6054G06K 19/06028G06Q 30/018A61J 1/2037A61M 5/19A61M 2205/502A61M 2005/3117G16H 20/17G06K 19/0723A61M 5/001A61M 5/002A61M 2205/6009G06K 19/06037A61M 5/284G16H 40/20G06Q 2220/00G06Q 50/265G06Q 50/22G06Q 50/04G06Q 30/01G06Q 10/30G06Q 10/101G06Q 10/08G06Q 10/063
67
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Mixing/administration systems and methods for preparing an agent for administration to an individual are disclosed. Caps may be included as part of the system, which may include compositions comprising at least one of a cleansing, antiseptic, antimicrobial, or disinfectant agent. The caps may additionally be included that may be used for hemostasis at an injection site. Packaging and/or the mixing/administration system within it may include a tracking mechanism for data tracking regarding many different aspects of the system, including aspects of manufacture and administration.

Claims

exact text as granted — not AI-modified
1 . (canceled) 
     
     
         2 . A system, comprising:
 at least one processor;   at least one memory device including a data store to store a plurality of data and instructions that, when executed, cause the system to:   
       receive from a first instance of an application executing on a first user device, manufacturing data for a medicament, wherein the medicament is housed in a syringe and the syringe is encased in a protective film including a tracking mechanism, 
       receive from the first instance of the application executing on the first user device and in association with the manufacturing data, a tracking mechanism identifier corresponding to the tracking mechanism included on the protective film; 
       store the manufacturing data, the tracking mechanism identifier, and an association between the manufacturing data and the tracking mechanism identifier; 
       receive the tracking mechanism identifier and administration data, wherein the administration data comprises data corresponding to administration of the medicament to a recipient, wherein the administration data comprises a geolocation of the administration; and 
       based at least on identifying the existence of the association between the tracking mechanism identifier and the manufacturing data, store the administration data and an association between the administration data and the manufacturing data. 
     
     
         3 . The system of  claim 2 , wherein the manufacturing data includes at least one of:
 a chemical composition of the medicament;   an expiration date of the medicament;   a lot number for at least one of the medicament or a vial containing the medicament;   a manufacturer of at least one of the medicament or the vial;   a date of manufacture of at least one of the medicament or the vial;   a time of manufacture of at least one of the medicament or the vial; or a location of manufacture of at least one of the medicament or the vial.   
     
     
         4 . The system of  claim 2 , wherein the one or more servers are further configured to:
 receive at least some of the manufacturing data and a request for the geolocation of the administration of the medicament; and   transmit based at least in part the association between the administration data and the manufacturing data, the geolocation of the administration of the medicament.   
     
     
         5 . The system of  claim 2 , wherein the administration data further comprises at least one of:
 a date of the administration of the medicament;   a time of the administration of the medicament;   an identifier of the recipient of the medicament, wherein the identifier can include one or more of a name, date of birth, and/or an identifying number;   a place of residence of recipient;   a geolocation of the administration;   demographic information of the recipient;   a name of a person performing the administration;   a dosage number; and/or   at least one vital sign of the recipient.   
     
     
         6 . The system of  claim 2 , wherein the tracking mechanism comprises at least one of a linear barcode, a 2D barcode, a QR code, a datamatrix code, a PDF417 code, or a RFID tag. 
     
     
         7 . The system of  claim 2 , wherein the tracking mechanism comprises at least one of a linear barcode, a 2D barcode, a QR code, a datamatrix code, a PDF417 code, and wherein the tracking mechanism is printed on at least one of the protective film or a label affixed to the protective film 
     
     
         8 . The method of  claim 7 , wherein the tracking mechanism is additionally printed on at least one of the syringe or a label affixed to the syringe. 
     
     
         9 . The system of  claim 2 , wherein the tracking mechanism is included on a label affixed to the protective film, wherein the label further includes a viability indicator, wherein the viability indicator detects and indicates exposure of the label to a level of at least one of light or heat that could compromise viability of the medicament. 
     
     
         10 . The system of  claim 2 , wherein the tracking mechanism comprises a RFID tag, and wherein the RFID tag is affixed to the protective film 
     
     
         11 . The system of  claim 2 , wherein the tracking mechanism comprises at least one RFID tag, and wherein a first RFID tag is included on the protective film and a second RFID tag is affixed to the syringe. 
     
     
         12 . The system of  claim 2 , wherein the one or more servers are further configured to:
 receive additional administration data, wherein the additional administration data is associated with a plurality of recipients of the medicament; and   based at least on the additional administration data, generate a report indicating a target geolocation for remediation of defects of the medicament.   
     
     
         13 . The system of  claim 2 , wherein the one or more servers are further configured to:
 receive additional data associated with a plurality of recipients of the medicament; and   determine trends, based at least in part on the additional data, associated with the plurality of the recipients.   
     
     
         14 . The system of  claim 2 , wherein the request is regarding at least one of a plurality of syringes, a plurality of barcodes, or a plurality of medicaments. 
     
     
         15 . The system of  claim 2 , wherein receiving the tracking mechanism identifier and the administration data comprises receiving the tracking mechanism identifier and the administration data from a second instance of the application executing on a second user device. 
     
     
         16 . The system of  claim 2 , further comprising:
 receiving, by a third-party device and from a second instance of the application executing on a second user device, the tracking mechanism identifier and the administration data; and   based at least on receiving the administration data, depersonalizing, by the intermediate computing device, the administration data via at least one of pseudonymization or anonymization,   wherein receiving, by the one or more servers, the administration data comprises receiving the depersonalized administration data from the third-party device.   
     
     
         17 . A device, comprising:
 at least one processor;   at least one memory device including a data store to store a plurality of data and instructions that, when executed, cause the system to:
 receive from a first instance of an application executing on a first user device, manufacturing data for a medicament, wherein the medicament is housed in a syringe and the syringe is encased in a protective film including a tracking mechanism, 
 receive from the first instance of the application executing on the first user device and in association with the manufacturing data, a tracking mechanism identifier corresponding to the tracking mechanism included on the protective film; 
 store the manufacturing data, the tracking mechanism identifier, and an association between the manufacturing data and the tracking mechanism identifier; 
 receive the tracking mechanism identifier and administration data, wherein the administration data comprises data corresponding to administration of the medicament to a recipient, wherein the administration data comprises a geolocation of the administration; and 
 based at least on identifying the existence of the association between the tracking mechanism identifier and the manufacturing data, store the administration data and an association between the administration data and the manufacturing data. 
   
     
     
         18 . The device of  claim 17 , wherein the manufacturing data includes at least one of:
 a chemical composition of the medicament;   an expiration date of the medicament;   a lot number for at least one of the medicament or a vial containing the medicament;   a manufacturer of at least one of the medicament or the vial;   a date of manufacture of at least one of the medicament or the vial;   a time of manufacture of at least one of the medicament or the vial; or a location of manufacture of at least one of the medicament or the vial.   
     
     
         19 . The device of  claim 17 , further comprising:
 receiving at least some of the manufacturing data and a request for the geolocation of the administration of the medicament; and   transmitting based at least in part the association between the administration data and the manufacturing data, the geolocation of the administration of the medicament.   
     
     
         20 . The device of  claim 17 , wherein the administration data further comprises at least one of:
 a date of the administration of the medicament;   a time of the administration of the medicament;   an identifier of the recipient of the medicament, wherein the identifier can include one or more of a name, date of birth, and/or an identifying number;   a place of residence of recipient;   a geolocation of the administration;   demographic information of the recipient;   a name of a person performing the administration;   a dosage number; and/or   at least one vital sign of the recipient.

Join the waitlist — get patent alerts

Track US2022118173A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.